Table 2 Risk stratification of monoclonal gammopathy of undetermined significance (MGUS).

From: Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders

IMWG Risk Category

Relative Risk of Progression

Absolute Risk of Progression at 20 years (%)

Absolute Risk of Progression at 20 years, accounting for death as a competing risk (%)

Low risk

 • M-protein <1.5 g/dL

 • normal sFLCR (0.26-1.65)

 • IgG isotype

1

5

2

Low-intermediate risk (any 1 factor being abnormal)

5.4

21

10

High-Intermediate Risk (any 2 factors abnormal)

10.1

37

18

High-risk (all three factors abnormal)

20.8

58

27

  1. IMWG international myeloma working group, sFLCR serum free light chain ratio [36]. © the American Society of Hematology.